What we did

Capitalmind Investec assisted Axience co-founders on defining the growth strategy of their group, and related business plan. We also helped structuring the right financing scheme to support the growth plan and then solicited heads of terms from a pool of banks, and ultimately negotiated best terms with shortlisted banks.

About the deal

Axience is a French privately-owned veterinary laboratory marketing third party drugs (anesthesia & analgesia) & nutritionals for pets & livestocks as well as disinfection products for vet clinics.

Axience secured a capex line underwritten by Société Générale and Crédit du Nord to finance upcoming NPD investments (drugs).


Deal Type
Target Headquarter
March 2020